DE69011588D1 - Pharmazeutische Formulierungen mit anhaltender Freisetzung. - Google Patents

Pharmazeutische Formulierungen mit anhaltender Freisetzung.

Info

Publication number
DE69011588D1
DE69011588D1 DE69011588T DE69011588T DE69011588D1 DE 69011588 D1 DE69011588 D1 DE 69011588D1 DE 69011588 T DE69011588 T DE 69011588T DE 69011588 T DE69011588 T DE 69011588T DE 69011588 D1 DE69011588 D1 DE 69011588D1
Authority
DE
Germany
Prior art keywords
sustained release
pharmaceutical formulations
release pharmaceutical
ketoprofen
awater
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69011588T
Other languages
English (en)
Other versions
DE69011588T2 (de
Inventor
Gordon Thomas Simpkin
Isabelle Husson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Application granted granted Critical
Publication of DE69011588D1 publication Critical patent/DE69011588D1/de
Publication of DE69011588T2 publication Critical patent/DE69011588T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE69011588T 1989-06-16 1990-06-14 Pharmazeutische Formulierungen mit anhaltender Freisetzung. Expired - Fee Related DE69011588T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898913889A GB8913889D0 (en) 1989-06-16 1989-06-16 New compositions of matter

Publications (2)

Publication Number Publication Date
DE69011588D1 true DE69011588D1 (de) 1994-09-22
DE69011588T2 DE69011588T2 (de) 1994-12-15

Family

ID=10658565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69011588T Expired - Fee Related DE69011588T2 (de) 1989-06-16 1990-06-14 Pharmazeutische Formulierungen mit anhaltender Freisetzung.

Country Status (9)

Country Link
US (1) US5188841A (de)
EP (1) EP0403383B1 (de)
JP (1) JPH0363220A (de)
AT (1) ATE109975T1 (de)
CA (1) CA2019108A1 (de)
DE (1) DE69011588T2 (de)
DK (1) DK0403383T3 (de)
ES (1) ES2068353T3 (de)
GB (1) GB8913889D0 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
EP1252886A1 (de) * 2001-04-27 2002-10-30 Universiteit Gent Pharmazeutische Pelletformulierungen für eine kontrollierte Freisetzung
GB0025208D0 (en) 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
CA2434169C (en) * 2001-01-12 2011-03-15 Sun Pharmaceutical Industries Limited Spaced drug delivery system
MXPA03008997A (es) * 2001-04-10 2004-02-12 Sun Pharmaceutical Ind Ltd Composicion de liberacion por impulso temporizado.
WO2002094321A1 (fr) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions favorisant la guérison d'une fracture osseuse
ES2427930T3 (es) 2001-05-23 2013-11-04 Mitsubishi Tanabe Pharma Corporation Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
GB0205253D0 (en) 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
KR100628263B1 (ko) * 2002-08-21 2006-09-27 엘지.필립스 엘시디 주식회사 액정표시소자
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
EP1615619A2 (de) * 2003-04-23 2006-01-18 Ferring B.V. Sachet für pharmazeutische zubereitungen
EP2112920B1 (de) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten
US8273371B2 (en) 2003-06-27 2012-09-25 Johan Adriaan Martens Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
GB0315012D0 (en) 2003-06-27 2003-07-30 Leuven K U Res & Dev Zeotiles
EP1547601A1 (de) * 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US8815285B2 (en) * 2006-03-28 2014-08-26 Wockhardt Ltd. Extended release dosage forms of metoprolol
EP1839649A1 (de) * 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Beschichtete Formulierung von Tolterodine
CA2648280C (en) * 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP1935405A1 (de) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Im Mund zerfallende Tabletten
JP5452236B2 (ja) * 2007-03-02 2014-03-26 ファーナム・カンパニーズ・インコーポレーテッド ロウ様物質を用いた徐放性組成物
US10668012B2 (en) * 2008-09-04 2020-06-02 Farnam Companies, Inc. Chewable sustained release formulations
CN102813638A (zh) * 2011-06-07 2012-12-12 贵阳医学院 一种右旋酮洛芬氨丁三醇双层缓释片的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1097220A (en) * 1975-10-10 1981-03-10 Aaron L. Weiss Controlled release tablet
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IE861284L (en) * 1986-05-14 1987-11-14 Birex Res And Dev Ltd And Carm Controlled release ketoprofen.
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations

Also Published As

Publication number Publication date
JPH0363220A (ja) 1991-03-19
EP0403383A1 (de) 1990-12-19
US5188841A (en) 1993-02-23
EP0403383B1 (de) 1994-08-17
GB8913889D0 (en) 1989-08-02
ES2068353T3 (es) 1995-04-16
DK0403383T3 (da) 1994-09-12
DE69011588T2 (de) 1994-12-15
CA2019108A1 (en) 1990-12-16
ATE109975T1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
ATE109975T1 (de) Pharmazeutische formulierungen mit anhaltender freisetzung.
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
ATE203400T1 (de) Pharmazeutische formulierungen
DE69525148T2 (de) Pharmazeutische formulierung
NO308303B1 (no) Vannløselige rapamycinestere, anvendelse derav samt farmasøytisk blanding som omfatter forbindelsene
DE69622735D1 (de) Lyophilisierte stabile pharmazeutische formulierung
FR2624732B1 (fr) Formulation pharmaceutique a liberation prolongee
DE69621885T2 (de) Neue galenische orale pharmazeutische formulierung
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
MA26576A1 (fr) Formulation pharmaceutique orale a liberation prolongee
FI973471A (fi) Pyratsol-4-yylibentsoyylijohdoksia ja niiden käyttö herbisideinä
MA26577A1 (fr) Formulation pharmaceutique orale a liberation pulsee
ATE234078T1 (de) Pharmazeutische omeprazol-formulierung
ES2020277B3 (es) Formulacion para la liberacion sostenida de ibuprofen.
NO981008D0 (no) Farmasöytisk formulering
FI925778A (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
DZ1926A1 (fr) Formulations pharmaceutiques.
NO975567L (no) Preparat med kontrollert frigivelse av aktiv substans
AU6090790A (en) Microencapsulated taste-masked water-insoluble nsaid drug materials
DK0861025T3 (da) Pesticidformuleringer
ES2086576T3 (es) Formulaciones de liberacion sostenida de acetazolamida.
FI973230A (fi) Uusi farmaseuttinen formulaatio
ATE142880T1 (de) Penciclovir enthaltende pharmazeutische formulierung
EE03658B1 (et) Pestitsiidpreparaadid ja protsess nende valmistamiseks

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee